Skip to content

Virtual Imaging-based Early Portal Pressure Gradient (vePPG) (CHESS1702)

Virtual Imaging-based Early Portal Pressure Gradient (vePPG) After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03177499
Acronym
vePPG
Enrollment
0
Registered
2017-06-06
Start date
2017-08-24
Completion date
2019-01-31
Last updated
2019-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Portal

Keywords

Portal pressure gradient, Transjugular intrahepatic portosystemic shunt, Virtual imaging-based portal pressure gradient

Brief summary

Portal pressure gradient (PPG) above 12 mmHg after transjugular intrahepatic portosystemic shunt (TIPS) increases the risk of portal hypertension complications. Currently, a PPG reduction \<12 mmHg after TIPS is the most consistent threshold associated with almost complete protection from variceal bleeding and ascites. However, the measurement of PPG requires an invasive procedure. A recent study investigated the variations in PPG measurements collected at different time points after placement of TIPS and demonstrated that a time point of at least 24 hours after which PPG values were best maintained (early PPG). It is of great clinical value to propose that an immediate PPG measurement fail to accurately identify the risk of decompensated event. And early PPG would change the decision making for re-intervention or not. However, the repeated invasive examination is extremely difficult to follow in clinical practice worldwide. The prospective multicenter trial aims to assess the diagnostic performance of a virtual imaging-based early portal pressure gradient (vePPG) (investigational technology) from CT angiography and Doppler ultrasound with invasive early PPG measurement as reference. The study participants with portal hypertension will be prospectively recruited at 10 high-volume liver centers in China.

Detailed description

Portal pressure gradient (PPG) above 12 mmHg after transjugular intrahepatic portosystemic shunt (TIPS) increases the risk of portal hypertension complications. Currently, a PPG reduction \<12 mmHg after TIPS is the most consistent threshold associated with almost complete protection from variceal bleeding and ascites. However, the measurement of PPG requires an invasive procedure. A recent study investigated the variations in PPG measurements collected at different time points after placement of TIPS and demonstrated that a time point of at least 24 hours after which PPG values were best maintained (early PPG). It is of great clinical value to propose that an immediate PPG measurement fail to accurately identify the risk of decompensated event. And early PPG would change the decision making for re-intervention or not. However, the repeated invasive examination is extremely difficult to follow in clinical practice worldwide. The prospective multicenter trial aims to assess the diagnostic performance of a virtual imaging-based early portal pressure gradient (vePPG) (investigational technology) from CT angiography and Doppler ultrasound with invasive early PPG measurement as reference. The study participants with portal hypertension will be prospectively recruited at 10 high-volume liver centers (Beijing Shijitan Hospital; 302 Hospital of PLA; Nanfang Hospital, Southern Medical University; The Third Xiangya Hospital of Central South University; Xingtai People's Hospital; Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University; First Affiliated Hospital, Sun Yat-Sen University; Beijing Ditan Hospital; PLA Army General Hospital; Third Affiliated Hospital, Sun Yat-Sen University) in China.

Interventions

PROCEDUREInvasive PPG

Invasive PPG obtained by means of catheterization.

Sponsors

Beijing Shijitan Hospital, Capital Medical University
CollaboratorOTHER
Beijing 302 Hospital
CollaboratorOTHER
The Third Xiangya Hospital of Central South University
CollaboratorOTHER
Xingtai People's Hospital
CollaboratorOTHER
Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University
CollaboratorUNKNOWN
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Beijing Ditan Hospital
CollaboratorOTHER
PLA Army General Hospital
CollaboratorUNKNOWN
Third Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Nanfang Hospital, Southern Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients providing written informed consent * Patients with portal hypertension and received the placement of TIPS * Patients with invasive immediate PPG and early PPG measurement * Has undergone \> 64 multi-detector row CT angiography and Doppler ultrasound within 3 days prior to invasive early PPG measurement

Exclusion criteria

* Any severe adverse events after TIPS placement * Inability to adhere to study procedures * Prior devascularization operation * Has received a liver transplant * Patients with known anaphylactic allergy to iodinated contrast * Pregnancy or unknown pregnancy status * Patient requires an emergent procedure * Any active, serious, life-threatening disease

Design outcomes

Primary

MeasureTime frameDescription
vePPG Numerical Correlation1 dayCorrelation of vePPG numerical value with early PPG numerical value

Secondary

MeasureTime frameDescription
Immediate PPG Numerical Correlation7 daysCorrelation of immediate PPG numerical value with early PPG numerical value
Diagnostic Performance of vePPG1 dayAccuracy, sensitivity, specificity, positive predictive value and negative predictive value of vePPG to determine re-intervention or not when compared to invasive early PPG as reference (PPG≥12mmHg)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026